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Abstract
Filariasis is one of the most debilitating tropical neglected diseases with high
morbidity rate and less rate of mortality with various clinical symptoms. According
to the World Health Organization (WHO) reports, about 120 million people from
81 countries are infected at present, and an estimated 1.34 billion people live in
areas endemic to filariasis and are at risk of infection. Currently available drugs are
only effective against the larval stage of the worms with side effects, and their
repetitive use gives rise to drug resistance. Till date, no effective vaccine is available
for the treatment of filariasis; to fulfill this need, new drug development becomes
the priority for the researchers. This chapter reviews different synthetic and natural
origin drugs, drug targets, and use of bioinformatics to discover new antifilarial
agents which can control this debilitating disease, including the types of filariasis,
their prevalence, and eradication programs which are discussed.
Keywords: filariasis, drug targets, antifilarials, bioinformatics
1. Introduction
A variety of parasitic diseases which are associated with morbidity and mortality
have received less attention worldwide. Among these, filariasis is one of the most
debilitating neglected tropical diseases. Filariasis is a vector-borne disease transmit-
ted by arthropod vector which is endemic in the tropics and subtropics that results
in social stigma. It is a group of human and animal infectious diseases caused by
nematode parasites generally called “filariae” that include several hundred species
of worms that are slender and elongated and are parasitic in tissues of various
vertebrate hosts. This parasite known to cause human infections belongs mainly to
the generaWuchereria, Brugia, Onchocerca, Dipetalonema,Mansonella, and Loa.
They reside either in lymphatics or muscles, connective tissues, body cavities, etc.
of vertebrate hosts. They may be classified into three main groups based on the
habitat of the adult worm, i.e., the cutaneous group, the lymphatic group, and the
body cavity group. Based on the habitat of the adult worm, a few of the filarial
species infecting man and the disease caused by them with their intermediate hosts
are listed in Table 1. The infection is transmitted by intermediate hosts which are
always blood-sucking arthropods of the order Diptera. Only two genera,Wuchereria
and Brugia, are mainly responsible for human lymphatic filariasis. The common
animal parasites are Setaria digitata and S. cervi (bovine), Dirofilaria immitis (dog),
D. uniformis (rabbit), Litomosoides carinii and Dipetalonema vitae (gerbils), Brugia
pahangi (cat), and Acanthocheilonema viteae (jird).
According to recent surveys, about 120 million people in 81 countries of the
world are infected from this disease, and 1.34 billion people who live in endemic
areas are at high risk of this life-threatening infection [1]. To eradicate filariasis
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globally, research plans are needed to design effective drugs and drug targets, new
vector control strategies, and diagnostic techniques. At the same time, the treat-
ment of filariasis also requires disease-specific clinical care and patient education
with counseling to eradicate this disease. Moreover, statistical analysis along with
bioinformatics tools of the mass drug administration (MDA) surveillance reports
should be carried out which could provide new opportunities to get an insight into
the proteins or genome which may contribute to its inhibition process.
In current surveillance report, five World Health Organization (WHO) regions
are endemic with lymphatic filariasis (LF). Worldwide, 1.39 billion people require
preventive chemotherapy. In Southeast Asia region, 877 million people of 9 coun-
tries and 432 million people of 39 countries in the Africa region are brutally affected
from this disease and require proper treatment. From the Western Pacific Region
which includes the Mekong Plus region and the Pacific region, nearly 40 million
people are at a risk of lymphatic filariasis. Cambodia, China, Cook Islands, Niue,
the Marshall Islands, Palau, the Republic of Korea, Tonga, Vanuatu, Viet Nam,
and Wallis and Futuna are the countries of this region that successfully eradicated
this disease, whereas American Samoa, Brunei Darussalam, Fiji, French Polynesia,
Kiribati, Lao People’s Democratic Republic, Malaysia, Federated States of
Micronesia, New Caledonia, Papua New Guinea, Philippines, Samoa and Tuvalu
are the 13 countries where lymphatic filariasis remains endemic [1, 2].
2. History of filariasis
In India first, ancient documented evidence of filariasis was reported in Sushruta
Samhita (approximately 600 BC) by the famous physician Sushruta. According to
some records, the first reliable documentation of filariasis was reported in the late
fifteenth and early sixteenth centuries. In 1849 William Prout explained the patho-
logical condition of chyluria in which the passage of lymph occurs in urine, a
condition associated with lymphatic filariasis. The French surgeon Jean Nicolas in
1863 was the first person who observed the microfilariae in the hydrocele fluid.
For the first time, in 1872 Timothy Lewis observed the microfilariae in the human
blood in India. In 1876, Joseph Bancroft recovered female filarial worms and named
them Filaria bancrofti, which later merged in the genusWuchereria. In 1877, Sir
Patrick Manson discovered the main cause of transmission of filariasis, by studying
the parasitic development of microfilariae in the mosquito stomach that was fed on
Filarial worm Habitat Intermediate host Disease
Wuchereria
bancrofti
Lymphatics Mosquito sp. Elephantiasis
Brugia malayi Lymphatics Mosquito sp. Malayan
filariasis
B. timori Lymphatics Mosquito sp. Timor fever
Loa loa Connective tissue Chrysopsis sp. (C. dimidiata)—Horse
flies
Loaiasis
Mansonella ozzardi Serous
membranes
Culicoides sp. (C. furens)—biting midges Ozzard’s filaria
Onchocerca volvulus Skin Simulium sp. (S. damnosum)—black flies Onchocerciasis
Table 1.
List of filarial worms with their habitats and intermediate host infecting humans.
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the blood of an infected gardener and thus reported that filariasis is transmitted by
the mosquito. In 1960 and 1977, two other filarial worm species were identified and
named as Brugia malayi and B. timori, respectively.
3. Filariasis: an overview
Among all the filariasis, lymphatic filariasis is the most debilitating which causes
disability in humans.Wuchereria bancrofti and Brugia malayi or B. timori are the
main cause of lymphatic filariasis, each of which is transmitted by the bite of a
specific insect vector. The various vectors that cause LF belong to the genera
Anopheles, Culex, Aedes, andMansonia. According to the WHO, increase in the
microfilarial density in the infected individuals and the feeding rate of vector
population are the causes of high transmission rates of filariasis in a particular area.
Onchocerca volvulus and Loa loa are the two other filarial worms that reside in the
cutaneous and subcutaneous tissues of the host and cause onchocerciasis and
loaiasis, respectively.Wuchereria bancrofti and O. volvulus are the two filarial worms
which do not require an animal host as reservoir.
Data collected from the survey depicted the picture of depressive illness of an
individual caused by LF and estimated 5.09 million disability-adjusted life years
(DALYs) [3–5]. In infants microfilaremia starts at the age of 5 after acquiring
infection, but the actual signs of filariasis (including hydroceles) appear during
puberty. Previous survey reports indicated that once the individual acquired infec-
tion chances of cure becomes very low [6].
Filarial worms inhabiting the lymphatic system live up to 8 years and release
millions of microfilariae into the bloodstream. TheWHO started the Global Alliance
to Eliminate Lymphatic Filariasis (GPELF) in 2000 with the goal of eradicating this
disease by 2020 through the use of MDA [7]. In the history of public health, GPELF
is the most successfully expanding global health program. Fifty-three out of the 81
endemic countries have started mass drug administration to halt the transmission of
filariasis. Two strategies have been developed to achieve the target of eliminating
filariasis. According to the first strategy, single annual doses of diethylcarbamazine
or ivermectin plus albendazole will be provided to the entire endemic area to
prevent the disease. The second strategy is to reduce disability rate by providing
knowledge about how to maintain hygiene and skin care, to those with lymphedema
and performing surgery in patients with hydrocele. The investment for chemother-
apy to control this disease is approximately US$ 105–208 million per year during
2015–2020. The WHO determined two objectives, which include “70% of endemic
countries demanding MDA will have to enter post-intervention surveillance by
2016” and “all other endemic countries have to complete the post-intervention
surveillance by 2020” [8, 9]. The abovementioned antifilarial drugs are only effec-
tive against the microfilariae and have no effect on the adult worms which therefore
provide a partial treatment to the infected individuals. Repetitive use of these drugs
resulted in drug resistance. Till date no vaccines are developed, and treatment
depends only on the antifilarial. Researchers are developing various new antifilarials
and combination therapies to overcome this disease [10].
4. General life cycle of filarial worm
Man is the definitive host of filarial worm, in whose lymphatic system, the adult
worms reside. Adult females discharge the live embryo called microfilariae (290 μ).
Microfilariae flow in the peripheral blood and can survive for a considerable time
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without undergoing metamorphosis until they are taken up by the intermediate
host, i.e., the culicine mosquitoes during their blood meal. After reaching in the
mosquitoes, microfilariae undergo development and become infective-stage larvae
as described in Figure 1.
5. Diagnosis of lymphatic filariasis
LF is primarily diagnosed using the immunochromatographic card test kit via
antigen detection methods (which also detects latent infections). The traditional
diagnosis of LF is performed by microscopy to detect circulating microfilariae.
Molecular xenomonitoring of parasites in mosquitoes, serological testing, ultraso-
nography, PCR tests, lymphoscintigraphy, detection of exposure to transmission in
children via antibody detection, and the recently introduced filariasis test strip
(FTS) are some of the other diagnostic approaches that are currently used.
6. Biological point for designing new drug
A clear knowledge of parasite physiology is very important to identify drug
targets for understanding the mode of action of antifilarial drug. Sometimes com-
pounds are also tested, without prior knowledge of the target. Compounds which
are effective against the whole parasite are defined as hits, while compounds that
are found to be active in vivo are considered as leads. Lead compounds require
standardization for increasing their efficacy. Once a compound is optimized, it can
be tested clinically in patients and defined as a “drug candidate.” Based on the
physiological processes and symptoms, a drug should be formulated and designed
to combat the disease. To overcome filariasis a number of drug targets should be
covered for developing new antifilarial, viz., macrofilaricidal and microfilaricidal
Figure 1.
Life cycle of filarial worm Setaria cervi given by Prof. Wajihullah and Dr. Sharba Kausar.
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drugs, drugs preventing exsheathment in microfilariae and drugs that can cause
hindrance in the movement of microfilariae. Different biochemical pathways are
summarized in Table 2 which are used in designing new drugs. On the other hand,
Wolbachia bacteria
Wolbachia are proteobacteria
61 potential drug targets
(outer membrane proteins,
ribosomal proteins, DNA
polymerases, mutases, ligases,
isomerases, cell division
proteins, transferases,
synthetases, reductases, etc.)
and four potential vaccine
extracellular targets such as
putative peptidoglycan lipid II
flippase, deoxycytidine
triphosphate deaminase, GTP
cyclohydrolase II, and RNA
pyrophosphohydrolase
Contribute to the nucleotide
pool of nematodes
Tetracycline was resulted in the
depletion of theseWolbachia resulting
in the upregulation of phosphate
permease gene, required for
nucleotide synthesis Another study
with doxycycline showed that
Wolbachia depletion was associated
with a reduction in the levels of
vascular endothelial growth factors
(VEGFs) that are essential for
lymphangiogenesis (18)
Wolbachia cell division
protein FtsZ a GTPase
Bacteria-specific filamenting
temperature-sensitive protein
(important in bacterial
cytokinesis) that was
expressed in all
developmental stages of B.
malayi
E. coli FtsZ inhibitor berberine, a
natural alkaloid, was examined by
researchers against GTPase activity of
FtsZ in B. malayi, and it was observed
that at 10–40 mM concentration,
berberine had adversely affected
production of microfilariae as well as
motility of adult females of B. malayi
N-Myristoyltransferase
Myristoyltransferase (NMT) The addition of myristic acid,
a 14-carbon unsaturated fatty
acid, to the N-terminus of
glycine in a subset of proteins
via myristoyl-CoA:protein N-
myristoyltransferase (NMT)
promotes their binding to cell
membrane
A known NMT enzyme inhibitor in
tripanosomatids, DDD85646, and its
analog DDD100870, were tested
against B. malayi NMT proteins and
provided IC50 values of 10 nM and
2.5 nM, respectively
Proteins and amino acids
Free amino acids are required for
intracellular osmoregulation and
protein synthesis
S-adenosylmethionine
methyltransferase, methionine
adenosyltransferase, and
S-adenosylhomocysteine
hydrolase
Are required for the conversion
of methionine to homocysteine in
the methionine
Enzyme prolyl-4-hydroxylase
has been reported to
Play a vital role in the
biosynthesis of this collagen
Transaminoglutamase Play a significant role in the
growth, development, and
maturation of the nematode
A pseudosubstrate,
monodansylcadaverine (MDC),
and active site inhibitors
cystamine or iodoacetamide were
found to inhibit L3-stage parasite
mobility in a dose-dependent
manner that was associated with
irreversible biochemical lesions,
resulting in the death of the
parasite
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Proteins and amino acids
Retinoic acid-binding proteins
(RABPs)
Parasitic nematodes require
lipophilic retinol for various
biological processes, such as
embryogenesis, differentiation,
and growth
For inter- as well as intracellular
movement
Ivermectin(II) was found to
compete efficiently with retinol
for the retinol-binding sites on
RBP of the parasite but not for
the host RBP sites
Biogenic amines and polyamines
Norepinephrine (NE),
histamine, 5-
hydroxytryptamine (5-HT),
and dopamine
Biogenic amines play a role in
neuromuscular activity and
behavioral coordination in
nematodes
Monoamine oxidase (i.e.,
MAO), acetylcholinesterase,
and dopamine-b-hydroxylase
DEC, levamisole, and
centperazine were found to
inactivate these enzymes
Dopamine-b-hydroxylase
Octopamine
Putrescine, spermine, and
spermidine
Are required for growth,
differentiation, and
macromolecular synthesis in all
living organisms as constituents
of the polyamine salvage
pathway
S-adenosylmethionine
decarboxylase (SAMDC)
Which is required for polyamine
biosynthesis
Berenil and aromatic
methylglyoxal bis
(guanylhydrazone) analogs are
inhibitors of an important
regulatory enzyme
Carbohydrate metabolism
Fructose 1,6-diphosphate
aldolase
Its immunogenic component in
filarial worms is distinguishable
from that of mammals, thus
identifying it as possible vaccine
target238
Phosphoenolpyruvate
carboxykinase
Inhibited by DEC
Fumarate reductase Inhibited by DEC and
benzimidazoles
Succinate dehydrogenase Inhibited by DEC
Phosphofructokinase Blocked by antimonial stibophen
in B. pahangi and L. carinii when
compared to isofunctional
mammalian enzyme
Glucose uptake Altered by DEC, amoscanate, and
arsenicals
Utilization of glucose Decreased by levamisole
Lipid metabolism
Quinones Play a role in filarial electron
transport
Geranyl geraniol Unknown role The biosynthesis of genanyl
geraniol and dolichols was
inhibited by mevinolin
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vaccine development and mosquito repellent practices such as the use of insecticide
nets, body lotions, insecticides spray, coils, etc. along with good knowledge of
sanitization can prevent vector development which together helps in combating
filarial worm infection in a community. The pathology associated with lymphatic
filariasis like elephantiasis, hydrocoele, and lymphedema is due to the hyporespon-
siveness of D4+ T cells of the host immune system [11–13]. Therefore, immunolog-
ical studies are also playing an important role in the field of drug development.
Drugs are also designed to combat symptoms associated with filariasis, viz., drugs
used for the treatment of lymphatic filariasis (drugs effective against adenolym-
phadenitis, funiculitis, epididymo-orchitis, lymphedema, hydrocele, chyluria,
Lipid metabolism
Juvenile hormones Regulators of larval development
Dolichols Required for glycoprotein
synthesis
Isopentyl pyrophosphate IPP constituent of filarial tRNA
HMG-CoA reductase is a rate
limiting enzyme
Involved in the isoprenoid
pathway of filaria
Inhibited by mevinolin
Folate metabolism
Enzymes, such as reductases,
transferases, synthases,
dehydrogenases, hydrolases,
mutases, ligases, and
deaminases
Are involved in the
interconversation of folate
analogs observed in the synthesis
of different tetrahydrofolate
cofactors by macrofilariae.
Specifically, dihydrofolate
reductase activity, which is
commonly observed in
macrofilariae, was found to be
absent in the microfilariae of
B. pahangi
DEC and suramin were found to
inhibit some enzymes involved in
folate metabolism
10-Formyl FH4 dehydrogenase
enzyme
Which was found to play a vital
role in the regulation of the
endogenous FH4 cofactor
concentrations, was more
active in B. pahangi than in
mammals
Glutathione
Glutamate-cysteine ligase
(rate-g-glutamyl
transpeptidase)
Glutathione has been proposed to
constitute the antioxidant system
(g-glutamyl cycle) that extends
the survival of filarial parasites in
mammalian hosts, thereby
protecting them from host-
mediated membrane lipid
peroxidation
Arsenicals depletes filarial
glutathione (262–264)
Phytocompounds such as
plumbagin, curcumin, and a
phenoxyacetic acid derivative
were found to inhibit filarial GST
In a report of a homology
modeling approach via in silico
analysis of the filarial GST of
B. malayi, albendazole, and a
methyl-substituted chalcone
showed non-competitive type of
inhibition of GST activity
Glutathione-transferases
(GSTs)
The major detoxifying systems in
filarial parasites and can detoxify
cytotoxic products of lipid
peroxidation via the conjugation
of glutathione (GSH) to various
endogenous xenobiotic
electrophiles
Table 2.
Antifilarial targets for designing drugs.
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chylocele, lymph scrotum) and drugs used in the treatment of other
manifestations like asymptomatic microfilaremia, occult filariasis, onchocerciasis,
and loaiasis.
7. Currently used antifilarial drugs
7.1 Diethylcarbamazine (DEC)
Diethylcarbamazine (DEC), a piperazine derivative, is the most common and
widely used drug over many decades. The antifilarial activity of DEC was first
tested against Litomosoides carinii- and Dirofilaria immitis-infected cotton rats
and dogs, respectively [8]. The observations revealed DEC as a potential
microfilaricidal agent. Clinical trial of DEC was started in 1947 against human
filariasis. Later, strong antimicrofilarial activity of DEC was also observed against
W. bancrofti, B. malayi, O. volvulus, and Loa loa infection in humans [14–17].
DEC acts rapidly by stimulating the host immune system. In some reports
macrofilaricidal effect of DEC was also recorded along with its antimicrofilarial
activity [18–21]. Peixoto et al. [22] described the direct mechanism of action of
this drug during their in vitro and in vivo studies; they observed apoptosis and
organelle damage ofW. bancrofti microfilariae by DEC [22]. To enhance the
effect of DEC against microfilariae, nitric oxide was induced by some researchers
and was found to be a good synergist [23]. However, DEC combined with
albendazole [24] revealed an effective killing ofW. bancrofti microfilariae, but the
combination therapy increased the development of hydroceles in the treated
patient [25].
7.2 Ivermectin (IVM)
It is a broad-spectrum anthelmintic and an effective macrofilaricidal drug intro-
duced in 1981 also known as Mectizan [2], which was the first commercially avail-
able macrocyclic lactone. Chemically, it is a 22,23-dihydro semisynthetic derivative
of avermectin B1, which is a fermentation product of actinomycetes S. avermitilis
discovered by Merck in the mid-1970s [11–32]. IVM alone or in combination with
DEC [8] resulted in long-term suppression of microfilariae in both bancroftian and
brugian filariasis [20, 33, 34].
7.3 Suramin
Suramin [35] initially was a drug used to cure trypanosomiasis and onchocerci-
asis. Chemically it is an 8,80-(carbonylbis[imino-3,1-phenylenecarbonylimino(4-
methyl-3,1-phenylene)carbonylimino])bis-1,3,5-naphthalenetrisulfonic acid
hexasodium salt. Presently it is the only macrofilaricidal drug that is effective
againstW. bancrofti and O. volvulus.
7.4 Albendazole
This anthelmintic drug is [24] a benzimidazole derivative. Recently this has
been used in a clinical trial to check out its efficacy as antifilarial drug [36]. Its
efficacy was increased when administered in combination with either DEC [8]
or IVM [2].
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Antifilarial agent Recommended dose Route of
administration
Mechanism of action Filarial worm Side effects
Diethyl
carbamazine
(piperazine
derivative)
6 mg/kg for 12 days (individual
treatment)
6 mg/kg in 24 hours (weekly/monthly/
single annual dose in mass treatment) for
treatingW. bancrofti infection
Oral Alterations in arachidonic acid
metabolism of host endothelial cells and
microfilariae, resulting in blood vessel
constriction and host granulocyte and
platelet aggregation; apoptosis and org
nelle damage
W. bancrofti
infection
Encephalitis and retinal hemorrhage.
Increasing dose include systemic reaction:
nausea, GIT upset, malaise, body aches,
and anorexia. Localized reactions: abscess
formation, lymphadenitis, and transient
lymphedema
3–6 mg/kg for 6–12 days (individual
treatment)
3–6 mg/kg in 24 hours (6 times at weekly
or monthly in mass treatment) for
treating B. malayi and B. timori infections
B. malayi and
B. timori
infections
8 mg/kg for 14 days
For the treatment of occult filariasis
Occult filariasis
Table salt +
Diethylcarbamazine
0.1% for 6 months treatment of LF W. bancrofti
(lymphatic
filariasis)
0.3% for 3–4 months B. malayi is endemic B. malayi
Ivermectin
(macrocyclic
lactone)
400 mg/kg single dose treatment
4800 mg/kg for 6 months treatment of B.
malayi and single dose remove
microfilariaeW. bancrofti
Oral Targets glutamate gated Cl- and K+ ion
channels in nematodes, results in
hyperpolarization that causes paralysis of
the body wall muscle and pharynx. The
drug also affects ligand-gated chloride ion
channels gated by GABA. It competes
with retinol for the retinol-binding site on
retinol-binding proteins (RBPs) in the
parasite only
Bancroftian
and brugian
filariasis
Same as DEC, and special care must be
considered, such as avoiding its use in
cases of pregnancy and in children
younger than 5 years old
Suramin 66.7 mg/kg in 6 incremental weekly doses
(3.3, 6.7, 10.0, 13.3, 16.7, 16.7 mg/kg for
the first and sixth weeks, respectively)
Intravenous
(10% solution
in water)
It adversely affects enzymes associated
with glucose catabolism and destabilizes
DNA and protein kinase enzymes in
filarial worms
W. bancrofti, O.
volvulus
Fatal collapse, albuminuria, ulceration,
and persistent high fever; polyuria,
tiredness, tenderness, anorexia, and
increased thirst; among others are some
of the milder side effects
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Antifilarial agent Recommended dose Route of
administration
Mechanism of action Filarial worm Side effects
Levimazol An initial dose of 100 mg followed by the
same dose twice daily for 10 days was
found to be as effective as the total oral
dosage of DEC at 126 mg per kg body
weight
Oral Acts as nicotinic receptor agonist that
causes prolonged activation of the
excitatory nicotinic acetylcholine (nACh)
receptors on the body wall muscle of
parasites, leading to spastic muscle
paralysis in the worm
W. bancrofti, B.
malayi
No side effects at recommended doses
Albendazole
(benzimidazole)
Albendazole+ DEC
Albendazole
(400 mg) + diethylcarbamazine (DEC)
(6 mg/kg)
Oral Block tubulin polymerization, thereby
inhibiting microtubule formation. It also
inhibits parasite intestinal cells,
preventing glucose uptake leading to the
death of the parasite
Macrofilaricidal Embryotoxicity and teratogenicity
Albendazole+
ivermectin
Albendazole (400 mg) + ivermectin
(150–200 mg/kg)
Table 3.
Summary of the recommended doses of currently used antifilarials.
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Antifilarial agent Action Parasite Dose Reference
Trisubstituted pyrimidine derivatives (the
amino group and 4-aminophenyl group at
the second position plays an important role
in exerting antifilarial activity)
ATP-dependent DNA topoisomerase II
inhibitory activity
S. cervi 10–40 mg/ml [38, 39]
2-Sulfanyl-6-methyl-1,4-
dihydropyrimidines
B. malayi (in vitro)
B. malayi–Mastomys coucha
25 and 50 μM
100 mg/kg
Indole derivatives B-carboline L. carinii–S. hispidus (cotton rats)
A. viteae–M. natalensis
30 mg/kg for 5 days
50 mg/kg for 5 days
[40–43]
b-Carbolines (substituted 9Hpyrido[3,4-b]
indoles)
L. carinii, A. viteae and B. malayi in a
M. coucha model
50 mg/kg for 5 days
Quinoline and related compounds 7-chloro-
4-(substituted amino)quinolines
A. viteae [44–47]
3-Nitro-4-quinolones via ipso-nitration Thymidylate kinase inhibitory activity Brugia malayi IC50 2.9 mM
Quinolones compound 7-chloro-4-
(substituted amino)quinolines
Evaluation against DNA topoisomerase II
enzyme, compound
Screened in vivo against A. viteae 200 mg/kg for 5 days
3-Nitro-4-quinolones Brugia malayi thymidylate kinase inhibitory
activity
B. malayi IC50 2.9 mM
Glycoside cinnamoyl glycosides S. cervi MIC (3.40 nM), IC50 (6.90 nM) and LC50
(25 nM) values, CC50 value of
approximately 103 nM
[48]
Cinnamoyl glycosides Chromatin condensation and DNA
fragmentation; this compound also
damaged the cuticular sheath of the
microfilariae
W. bancrofti MIC and IC50 values were 4.4 nM/ml and
8.96 nM/ml, respectively
Dioxocine 3,6-epoxy dioxocines B. malayi–M. coucha IC50 values (0.4 mg/ml and 1.8 mg/ml, with
selectivity indices (SI) of 100 and 22.2 with
respect to macrofilariae and microfilariae,
respectively
[49]
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Antifilarial agent Action Parasite Dose Reference
Compound B. malayi in jirid Found to be potent in terms of both in vitro
(IC50 1.6 mg/ml and 3.5 mg/ml for
macrofilariae and microfilariae,
respectively) and in vivo antifilarial
activity, 200 mg/kg
Alcohols cyclohexanol, 2- substituted
propanol
Cyclooctanol derivatives
A. viteae and L. carinii in rodents
A. viteae in rodent
100% macrofilaricidal activity (at a dose of
200 mg/kg for 5 days)
81% sterilization of female worms (at a dose
of 100 mg/kg for 5 days) against
[50]
Triazine DHFR (dihydrofolate reductase) inhibitors,
good inhibitory activity (approximately
74%) against PARP (polyadenosine
diphosphate ribose polymerase)enzyme
B. malayi Almost 100% loss of motility of filarial
worms at 20 mg/ml showed better activity
(IC50 10.90 mM) when compared with
standard antifolate (positive control)
compounds, i.e., trimethoprim (IC50
12.92 mM) and pyrimethamine (IC50
20.10 mM
[51, 52]
Benzopyran (coumarin) B. malayi–M. coucha
B. malayi–jirid model
When administered orally at a dose of
300 mg/kg for 5 days showed 53.6%
macrofilaricidal and 46% microfilaricidal
activity
At a dose of 100 mg/ kg for 5 days, showed
75% adulticidal and 50% microfilaricidal
activity
[53–55]
Naphthalene derivative 1,4-
naphthoquinones
1,3-Dimethyl substitution on the
butylamino side chain favors an increased
lipophilicity with potentially improved
binding to the active site, which results in
elevated macrofilaricidal activity (133)
Setaria digitata ED50 value of 2.6 mM after a 24 h
incubation and 0.91 mM after a 48 h
incubation
[56]
Thiazolidine heterocyclic thiazolidine
compounds compound (31) and compound
(32)
B. malayi IC50 values of 5.2 mM and 1.78 mM
LD50 values of 349 mM and 17.59 mM,
respectively
[14]
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Antifilarial agent Action Parasite Dose Reference
Butylated hydroxy anisole (BHA) Oxidative stress-induced apoptosis was
found to be its major killing mechanism
(135)
S. cervi At 100 mM was found to be a potent
adulticide
[15]
Piperazine benzoyl piperazine derivatives
(two compounds, viz., compound (34) and
compound (35) containing a 4-chloro
(para) substituent and 3-methyl (meta)
substituent on the aromatic ring)
S. cervi Worms were immotile following treatment
with these two compounds at a
concentration of 8 mg ml 1
[16, 17,
57]
Pyrrolidine chalcone derivative (36)
containing the pyrrolidine-methoxy group
Showed a significant suppression of
glutathione-S-transferase (GST) activity in
the macrofilariae of female S. cervi at a
concentration of 3 mM in vitro
S. cervi 100% inhibition
Diaminoalkane N1,Nn-xylofuranosylated
diaminoalkanes
B. malayi–M. coucha
B. malayi–jirid
At 50 mg kg 1 provided approximately
38.7% recovery of macrofilariae and 63.80%
sterilization of female parasites
The same compound also showed 33.5%
adulticidal action along with 50%
sterilization of female worms
[58]
Secondary amines A. viteae At a dose of 200 mg/kg for 5 days exhibited
100% macrofilaricidal activity, whereas
compound elicited a microfilaricidal
response of approximately 93%
[59]
Glycyrrhetinic acid derivatives and the
benzylamide analog
B. malayi Killing microfilariae and macrofilariae at 50
and 25 mM, respectively
The IC50 values were found to be 2.2 mM
against microfilariae and 8.8 mM against
macrofilariae of the worm
[60]
B. malayi–jirid At a dose of 100 mg/kg for 5 days exhibited
40% adulticidal activity
13 Fila
ria
sis
D
O
I:h
ttp
://d
x
.d
oi.org/10
.5772
/in
tech
op
en
.89454
Antifilarial agent Action Parasite Dose Reference
Nitazoxanide and tizoxanide The researchers further reported that both
compounds reduced microfilarial
production and impaired embryogenesis in
female worms. They also suggested that
mitochondria in the worms may be a
possible target of NTZ (41) and TZ (42)
because in addition to damaged worm
tissues, they found alterations in the
mitochondria
B. malayi Macrofilariae were found completely
immotile after 6 days when cultured with
these two compounds at concentrations of
20 mg/ml
On day 8 of culture at concentrations of
2.5 mg/ml, both drugs also caused a 50%
decrease in worm viability
Microfilarial motility was also hampered by
these compounds at concentrations
exceeding 5 mg/ml, and the worms were
completely immotile following treatment
with 20 mg/ml (after 48 h)
[61]
Nitazoxanide
Nitazoxanide + silver nanoparticles
Inhibit TCA cycle enzymes S. cervi 100% mortality of microfilariae at 100 μg/
ml
100% mortality of microfilariae at 30 μg/ml
[62, 63]
Anthraquinone 3-methylcatechol with a
substitution of acylium ions
Marked effects on intrauterine embryos of
parasite
B. malayi infection in humans At 5 ppm (18–19 mM) showed 100%
mortality within 1, 5, and 3 days against
microfilariae and adult male and female
worms
[64]
Sulfonamide sulfonamide chalcones B. malayi IC50 value was found to be 4.4 mM, LD50
value of 188 mMt 500 mM concentration
after 48 h of incubation
[65]
Benzothiazole novel chalcone–
benzothiazole hybrids
It showed higher binding interactions at the
active site of BmTMK (B. malayi
thymidylate kinase, an essential enzyme for
nucleotide metabolism in B. malayi).
B. malayi IC50 values of 2.12 mM and 1.63 mM,
respectively, for adult worms as well as
microfilariae
MIC value of 5 mM for both the forms
IC50 value was 95.3 mM
[66]
Thiazole chalcone–thiazole derivatives B. malayi–jirid
B. malayi–M. coucha
At a dose of 100 mg/kg for 5 days showed
100% embryostatic activity
Exerted approximately 49%
macrofilaricidal activity and
[67]
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Benzimidazole derivatives HOE 33258
mebendazole,
Flubendazole
2,20-Dicarbomethoxyamino-5,50-
dibenzimidazolyl ketone
At 5  2.5 mg/kg and 1  25 mg/kg in jirds
and 1  100 mg/kg in cats when
administered by subcutaneous injection
A dose of 3 mg/kg (i.p.) and 50 mg/kg
(oral)  5 days of Comp. 82/437
At a dose of 150 and 200 mg/kg for 5 days
L. carinii and D. immitis
Evaluated in jirds (Meriones
unguiculatus) and cats (Felis catus)
infected with Brugia pahangi
L. carinii in cotton rats
Dipetalonema viteae and Brugia
malayi inMastomys natalensis
Macrofilaricidal. It also killed developing
larvae in jirds. It was not microfilaricidal
Eliminated almost 100% of adult worms
and microfilariae
It killed 100% of the macrofilariae and 97%
of the microfilariae
[68–79]
Silver Nanosilver B. malayi LD50 concentration (by trypan blue
exclusion) of 101.2 mM and an IC50 value of
50.6 mM (complete microfilariae
population found immotile). At 4.6 mM
only, nanosilver caused a 50% decrease in
the motility of the parasite
[80]
Table 4.
List of synthetic and naturally originated antifilarials.
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Plant Extract Target Antifilarial efficiency Author
Streptomyces sp. 17,944 Three new tirandamycins B. malayi Inhibit the asparaginyl-tRNA-synthetase (BmAsnRS)
enzyme at an IC50 value of 30 mM
[81]
Streptomyces sp. 9078 Depsipeptide B. malayi IC50 value of 50 mM [82]
Streptomyces sp. 4875 Four adipostatins (alkyl resorcinols) potent among the
compounds
B. malayi Kill the worms at 1 mM concentrations [83]
Lantana camara Crude extract A. viteae LC100 62.5 μg/ml [84]
B. malayi LC100 500 mg/ml
Chloroform, n-butanol and aqueous B. malayi LC100 250 μg/ml
Fractions of n-hexane oleanonic acid B. malayi LC100 31.25 μg/ml
Oleanonic acid LC100 62.5 μg/ml
Crude extract 1 g/kg  5 days A. viteae/M. coucha model 95.05% reduction in Mf 23.65% effective against adult
B. malayi transplanted/
M. unguiculatus
80% effective against adult
Taxodium distichum A001 (crude ethanolic extract of aerial part)
F001 (hexane fraction)
K003(labda-8(20),13-diene-15-oic acid) and K004
(metasequoic acid A)
SF1 (fraction)
SF4 (fraction)
B. malayi mf (LC100 3.91 μg/ml) than adult worms
(LC100 15.63 μg/ml)
IC50 values for the respective parasite stages were found
to be 1.95 and 10.00 μg/ml
mf (LC100 7.83 μg/ml)
adult worms (LC100 31.25 μg/ml)
mf (LC100 31.25 μg/ml) and adult worms
(LC100 125 μg/ml)
mf (LC100 7.83 μg/ml) than adult (LC100 31.25 μg/ml)
mf (LC100 62.5 μg/ml) adult (LC100 125 μg/ml)
[85]
A001 (500 mg/kg  5 days; orally)
K003 (100 mg/kg  5 days) exerted
At 100 mg/kg dose, both K003 and K004
K003 (100 mg/kg  5 days)
B. malayi/M. unguiculatus
B. malayi/M. coucha model
100% effective against Adult
>95%; remarkable embryostatic
activity
Produced >25% macrofilaricidal
activity
Exerted 53.94% macrofilaricidal
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Azadirachta indica Alcoholic extract of flowers
Aqueous extract of flowers
S. cervi Mf(LC50 of 15 ng/ml)
(LC90 ¼ 23 ng/ ml),
mf(LC50 of 18 ng/ml)
(LC90 ¼ 25 ng/ ml)
[86–88]
Methanolic extract of leaves
Ethanolic extract of leaves
S. cervi Mf 100% mortality at 200 μg/ml in 135 min
Mf 90% mortality at 200 μg/ml in 135 min
Ethanolic extract of A. indica leaves S. cervi Showed significant worm reduction at 25 lg/ml and
highest mortality at 100 lg/ml after 24 h of incubation
when applied against the microfilariae
Eucalyptus tereticornis Ursolic acid obtained from the leaves B. malayi LC100 50 mM and IC50 8.84 mM against microfilariae,
and LC100 100 mM and IC50 35.36 mM against adult
worms
[89]
Senecio nudicaulis Aqueous leaf extract
Alcoholic leaf extract
Setaria cervi Both the extracts exhibited macrofilaricidal activity
LC50 10 ng/ml and LC90 15 ng/ml
LC50 5 ng/ml and LC90 12 ng/ml
[90]
Hibiscus sabdariffa n-Butanol insoluble fraction of leaf extract B. malayi At 250 mg/ml concentration demonstrated a high
microfilarial motility
[91]
At a dose of 500 mg/kg  5 days
1 g/kg  5 days
B. malayi–jirid model
B. malayi–M. coucha model
Showed 30% macrofilaricidal activity
Showed 57% macrofilaricidal activity
Trachyspermum ammi Methanolic extract of fruit
The 2-isopropyl-5-methyl phenol (thymol) was the
active component
Its positional isomer (i.e., 5-isopropyl-2-methyl phenol,
carvacrol,) also
showed promising result
S. digitata IC50 0.067 and 0.019 mg/ml after 24 h and 48 h,
respectively
IC50 were 0.024 mg/ml and 0.002 mg/ml after 24 h and
48 h incubation, respectively
Macrofilaricidal IC50 values were 0.025 mg/ml and
0.004 mg/ml after 24 h and 48 h incubation,
respectively.
[92]
2-Isopropyl-5-methyl phenol at a dose of 50 mg/ kg for
5 days
B. malayi–M. coucha Macrofilarial mortality of 58.93%
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Plant Extract Target Antifilarial efficiency Author
Bauhinia racemosa (B.
racemosa)
Galactolipid (n-butanol fraction) obtained from
ethanolic extraction of the leaves
B. malayi The MIC values against adult worms 3.9 mg/ml and
15.6 mg/ml against microfilariae
The IC50 values were 1.25 mg/ml and 1.607 mg/ml,
respectively, against adult worms and microfilariae
[93]
50 mg/kg  5 days B. malayi infection 58.3% adult worm mortality
Piper betel Crude methanolic at a dose of 100 mg/kg B. malayi–M. coucha Suppress mf most effectively and showed 26% efficacy
against adult worm
[94]
Hibiscus mutabilis Active ferulic acid, from the leaves S. cervi Approximately 97 and 90%, of reductions in viability of
microfilariae and adult worms, respectively
[95]
Caesalpinia bonducella Crude extract from the seed kernel B. malayi 96% macrofilaricidal activity [96]
Melaleuca cajuputi The flower extract B. pahangi Halted the release of mf and worm mobility after 6 days
at 1000 mg/ml
[97]
Xylocarpus granatum Aqueous–ethanolic extract
fruit extract
B. malayi IC50 value of 15.46 and 13.17 mg/ml against
macrofilariae and microfilariae, respectively
[98]
The ethyl acetate soluble fraction demonstrated An IC50 value of 8.5 and 6.9 mg ml
1 against
macrofilariae and microfilariae, respectively
At a dose of 50 mg/kg for 5 days B. malayi–M. coucha 53% macrofilaricidal and 63% embryostatic effects
Gedunin (64)
Photogedunin
Mf (IC50 2.03 mg/ml)
Adult (IC50 0.239 mg/ml)
Mf (IC50 2.23 mg/ml)
Adult (IC50 0.213 mg/ml)
Gedunin at a dose of 100 mg/kg for 5 days
Photogedunin at a dose of 100 mg/kg for 5 days
B. malayi–M. coucha Killed 80.0% of the transplanted adult worms
70.0% adult worm mortality
Vitex negundo (V. negundo)
and Aegle marmelos (A.
marmelos)
The root extract from V. negundo and the leaf extract
from A. marmelos
B. malayi At a concentration of 100 ng/ml caused a complete loss
of microfilarial motility after 48 h of incubation
[99]
Aegle marmelos Methanolic extracts of Aegle marmelos Corr. (Rutaceae)
leaves
S. cervi (IC50) was 0.168 mg/ml [100]
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Diospyros peregrina n-Butanol extract (NBE) of D. peregrina stem bark on
Setaria cervi
S. cervi Mf (IC50 56.1 μg/ml, (IC50), adult (IC50 57.6 μg/ml)
Mf (LD100 187.17 μg/ml) after 24 h of treatment
[101]
Cajanus scarabaeoides (L) The polyphenol-rich ethanolic extract obtained from
the stem part
S. cervi LD50 values were 2.5, 10 and 35 μg/ml, against the
oocytes, microfilariae (Mf) and adults, respectively
[102]
Ficus racemosa Alcoholic and aqueous extract of fruits of F. racemosa Setaria cervi LC50 and LC90 were 21 and 35 ng/ml, respectively, for
alcoholic, while for aqueous extracts were 27 and 42 ng/
ml, respectively
[103]
Botryocladia leptopoda The crude ethanolic extract from the marine red alga B.
leptopoda
A. viteae
L. sigmodontis
Brugia malayi
LC100 of 62.5 mg ml
1
LC100 of 31.25 mg ml
1
LC100 of 125 mg ml
1
[104]
At a dose of 200 mg/kg for 5 days L. sigmodontis–cotton rats
A. viteae–M. coucha and
B. malayi–M. coucha
Exhibited 71.6% 63.2% (ethanolic extract) and 45%
(hexane fraction) macrofilaricidal activity, respectively
Haliclona oculata The methanolic extract
Chloroform fraction and its one chromatographic
fraction
B. malayi Mf (IC50 5 mg/ml)
Adult (1.88 mg/ml)
Showed antimacrofilarial activity IC50 1.80 mg/ml and
1.62 mg/ml, respectively, whereas concentrations of
1.72 mg/ml and 1.19 mg/ml were effective against
microfilariae
[105]
At a dose of 100 mg/kg for 5 days the methanol extract,
chloroform fraction, and chromatographic fraction
(contain four major alkaloids: xestospongin-C,
araguspongin-C, mimosamycin, and xestospongin-D),
respectively
B. malayi–jirid Revealed 51.3%, 64% and 70.7% macrofilaricidal
activities in the methanol extract, chloroform fraction,
and chromatographic fraction, respectively.
Haliclona exigua Methanol extract, the n-butanol-soluble fraction
Chloroform fraction
Araguspongin C
B. malayi (LC100 31.25 mg/ml)
(LC100 15.6 mg/ml)
Macrofilaricidal activity at 15.6 mg/ml
[106]
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Eucalyptus globulus The leaf extract from E. globulus was active in vitro B. malayi IC50 values 62.5 and 31.2 mg/ml, respectively, against
adult worms and microfilariae
[107]
At a dose of 100 mg/kg for 5 days B. malayi–M. coucha model
and transplanted B. malayi
jirid
Exhibited 66.7% adulticidal activity and an
embryostatic effect
Terminalia bellerica,
Terminalia chebula,
Terminalia catappa
Leaf extracts in different solvents Setaria cervi The methanol extract exhibited more than 80% activity
at the highest dose level of 10 mg/ml. The IC50 obtained
in methanol extracts are 2.7, 1.96 and 2.58 mg/ml
[108]
Moringa oleifera The gum extract obtained fromM. oleifera showed at a
dose of 500 mg/kg for 5 days
In contrast, at a dose of 1000 mg/kg for 5 days
B. malayi
B. malayi–jirid
B. malayi–M. coucha
Mf (LC100 1000 mg/ml)
Adult (LC100 125 mg/ml)
Mf (IC50 > 1000 mg/ml)
Adult (IC50 74.33 mg/ml)
Extract showed 69% adulticidal activity and sterilized
83% of the female worms
Extract showed 44% adulticidal activity
[109]
Butea monosperma The leaf and root extract
Methanol and hexane–ethanol fraction of the leaf
extract
B. malayi
S. cervi
Microfilarial motility in a dose-dependent manner
Showed IC50 values of 1.25 and 3.6 mg/ml, respectively,
against macrofilariae
[110, 111]
Ricinus communis Methanolic extract of the seed B. malayi 90% death in the developmental stages of the parasite [112–114]
Rutin and hesperetin S. digitata Showed macrofilaricidal activity a 500 mg/ml
Naringenin B. malayi Showed macrofilaricidal activity at 125 mg/ml IC50
value at2.5 mg/ml
At 50 mg/kg B malayi–Meriones and B.
malayi-M. coucha
Eliminate adult worms 73 and 31%, respectively
Flavone
Chrysin
Exhibit macrofilaricidal activity at 62.5 mg/ml and
inhibit the adult motility at 31.2 mg/ml
Showed macrofilaricidal activity at 2.50 mg/ml
Table 5.
List of naturally originated antifilarials are summarized below.
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7.5 Levamisole
This is an ascaricidal drug with no side effects at the recommended doses. It has
also been found as a microfilaricidal drug against the microfilariae ofWuchereria
bancrofti and Brugia malayi [37].
Unfortunately, most of the chemical antifilarials are characterized by adverse side
effects. The list of currently used antifilarials with their side effects is summarized in
Table 3. Hence, researches on exploring new therapeutic drugs, especially less haz-
ardous drugs of natural origin, are highly recommended. The application of biomed-
icines to treat disease is among the oldest forms of therapy. These biomedicines
including plant extracts and their secondary metabolites were believed to exert their
bioefficacy through immunomodulatory elicitation of Th1/Th2 response, either by
single (Th1, Th2) or mixed adjuvant activity. Therefore, in the context of filariasis,
synthetic and naturally originated antifilarials are summarized in Tables 4 and 5.
8. Role of bioinformatics in filarial research
Bioinformatics is a science of computer-based analysis for the biological datasets
in which biology and computer science are mutually helping and influencing each
other in the field. Bioinformatics has increased the understanding of molecular
mechanism of various cellular processes. Nowadays bioinformatics covers several
fields of biological sciences and drug discovery to overcome biological problems.
8.1 Genomic approach in filarial research
Genomic research in bioinformatics is a useful technique used to understand the
structure and function of all the genes within an organism. Genomics help to find
the particular gene and other biological aspects in the entire genome sequence of the
organism. Screening of drug targets can also be done using the genomics approach.
Casiraghi et al. [115] had carried out phylogenetic analysis using bioinformatics of
11 filarial and Spirurida nematodes and identified the sequence of mitochondrial
cytochrome oxidase-I (COI).
Hoerauf et al. [116] detected the mutual interaction between the intracellular
bacteria (endobacteria) and filarial nematodes, which is further used as antifilarial
drug targets. Nuchprayoon et al. [117] identified the genetic diversity using phylo-
genetic analysis parsimony tool (PAUP) between the DNA sequences of two strains
ofWb found in Myanmar and Thailand. Ghedin et al. [118] reported the nuclear
genome draft of Bm (95-Mb), which contains 88,363,057 bp sequences with 17.84%
protein coding sequence [118]. The full genome sequences are available at
NEMBASE4 database. Investigators identified a variety of filarial parasite genes and
their novel functions that are involved in miRNA regulation and processing.
8.2 Proteomic approach in filarial research
Proteomics approach involved highly efficient methods of protein separation
like two-dimensional-poly acrylamide gel electrophoresis (2DPAGE) and detection,
using modern tools of bioinformatics. Proteomic analysis of the several stages of Bm
has identified 557 Bm proteins and 11,508 protein coding genes which helps to
define various proteins by using reverse-phase liquid chromatography-tandem
mass spectroscopy.
Afterwards Bennuru et al. [119] have also done the same in identifying the
excretory/secretory (ES) and somatic proteins of adult, mf, and infective stages of
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larvae of Brugia malayi. Some workers gathered the molecular information of the
particular protein of interest through 3D structure which plays a significant role in
drug designing and vaccine development for lymphatic filariasis. In 2005 Bhargavi
et al. [120] analyzed the 3D model of GST ofWuchereria bancrofti and Brugia malayi
for better drug development. For the development of potential drugs, novel drug
targets are modeled using bioinformatics approach including either ligand-based
drug designing (LBDD) or structure-based drug designing (SBDD). LBDD provides
crucial understanding of the interaction between the drug target and ligand mole-
cule and provides information about the biologically active molecules [121]. Cur-
rently 3D quantitative structural activity relationship (QSAR) and pharmacophore
modeling of small molecules are carried out to define their minimum necessary
structural characteristics through which it inhibits the target. These 3D structure
analyses of a protein were designed from the experimental-based method such as X-
ray crystallography, NMR, electron microscopy, etc. If an experimental data are not
available for the target proteins, homology modeling is carried out to build the 3D
structure using target protein sequence [122].
Potential inhibitor can be designed on the basis of their binding sites or can be
identified from the small-sized molecule databases such as Cambridge Structural
Database [123], ChemBank [124], DrugBank [125], PubChem [126], and ZINC
database [127] and databases that are available at Lignad.Info: molecule database
[128] to inspect the biological activity of the particular protein.
Name Description URL
DBEMFDD
diseases
database
It is an annotated bibliography for filariasis, malaria,
dengue, and diarrhea. It also contains the findings of
the literature survey
http://ideas.repec.org/p/ess/
wpaper/id2032.html
FilaDB Database on filaria detection, clinico-immuno
monitoring, and management has been developed for
Kasturba Hospital and private practitioners to screen
the filarial infection
http://www.jbtdrc.org/FilaDb.
htm
NEMBASE2 Contains the EST sequence for Brugia malayi and
other nematodes
http://www.nematodes.org/ne
matodeESTs/nembase.html
Filaria Journal Full and freely access journal of filariasis http://www.filariajournal.com/
Wormbase It is an online database for the biology and genome of
the Ce and related nematodes
http://www.wormbase.org
WHO It contains the related publication of filariasis, reports
of elimination program, control of neglected tropical
diseases and some important links
http://www.who.int/topics/fila
riasis/en/
PHIS It contains the news and updated from filariasis
elimination program
http://umis.doh.gov.ph/fila
Disease
database
It contains the general information regarding diseases http://www.diseasesdatabase.c
om/ddb4824.htm
TDR-
lymphatic
filariasis
It contains knowledge about the parasite genomes for
African lymphatic filariasis and other diseases TDR is
now focusing on providing capacity to use the parasite
genome data and on supporting developments in
applied genomics and bioinformatics
http://www.who.int/tdrold/d
iseases/lymphfil/default.htm
Filarial
worms
database
This database provides the genome sequence of
organisms rapidly and broadly available to the
scientific community.
http://www.broadinstitute.org/
annotation/genome/filarial_
worms/MultiHome.html
Table 6.
List of online databases for lymphatic filariasis are as follows.
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8.3 Web-based available resources for LF
Web-based biological data plays a significant role in bioinformatics which plays
a significant role in analyzing biological data for large amount of nucleotide
sequences, amino acid sequences, and 2D or 3D structures for the broad range of
organisms and their drug targets. Currently, there are only few databases available
for LF (Table 6), but the specified database for LF is not available, which is an
urgent need in the field of drug development and to overcome the emerging drug
resistance. Some of the important databases which are available for LF research
have been discussed below.
NEMBASE: It contains databases containing information of filarial nematodes
such as filarial biology and pathology, nomenclature of filarial genome, mapping of
filarial gene, and Bm genome survey sequencing (GSS). Recently, genome sequenc-
ing of wBm and Onchocerca volvulus (Ov) was also included with the Sanger Insti-
tute, NEB, and TIGR.
WormBase: It’s an open access database repository for nematode biology which
contains the genome browser for Bm, C. elegans, H. contortus, etc., and the gene
predictions and orthology assignments from a range of related nematodes.
FilaDB: It is a database for screening filarial patients with the objective of
providing information on the incidence of mf and types of acute, chronic, and
occult manifestations and age, sex, and distribution area of filariasis cases for
clinico-immuno monitoring and management of filariasis.
Filarial worm database at broad institute: This database used to study the minute
phenotypic difference between the closely related filarial species of Loa loa,Wb,
and Ov (http://www.filariasiscenter.org/brugia-malayigenomics-and-bioinformatics-re
sources). Filarial worm database also has the sequence data onWolbachia endosym-
bionts ofWb, Ov, and Bm. Filarial diseases are still remaining as a major public
health concern in India. There is a need of comprehensive database, which should
contain:
a. Curated links between genes relevant to filariasis and their sequences in
GenBank and Swiss-Prot.
b. Sequence homology between different filariasis causing genes.
c. Primary and secondary information of pathogens.
d. Availability of various drugs and their targets.
e. Expressed sequence tagged (EST) sequences from different filarial species.
f. Supporting references from published literatures.
g. Bioinformatics tools to analyze those data. Database should also contain the
epidemiological data on age and gender-wise incidences of disease, remission,
and transition rates of disease sequelae.
9. Conclusions
Filariasis is one of the most disabling and disfiguring neglected tropical diseases
with various clinical manifestations and a high morbidity rate. Repetitive use of
antifilarials has given rise to drug resistance. Most of them are effective against
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microfilariae and have no effect on the adult worms. Till date numbers of antifilarial
targets have been explored, but their evaluation with reference to assay feasibility,
target validation, drugability, toxicity, resistance potential, and structural informa-
tion needs to be discovered in the future. There is a need to explore the mechanism
through which drug resistance occurs so that new effective combination therapy
could be discovered at an early stage.
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